New Delhi: An expert panel of the country’s central drug authority has recommended granting emergency use authorization to the Serum Institute of India’s COVID-19 vaccine Covovax and Biological.
The Minister said that all these approvals will further strengthen the global fight against the pandemic adding that India s Pharma Industries are an asset for the entire world.